Medical Developments International Ltd (MVP) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.013x

Based on the latest financial reports, Medical Developments International Ltd (MVP) has a cash flow conversion efficiency ratio of 0.013x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$709.00K ≈ $501.66K USD) by net assets (AU$55.10 Million ≈ $38.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Medical Developments International Ltd market cap and net worth for the company's overall valuation and market capitalisation.

Medical Developments International Ltd - Cash Flow Conversion Efficiency Trend (2004–2025)

This chart illustrates how Medical Developments International Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Medical Developments International Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Medical Developments International Ltd ranked by their cash flow conversion efficiency. Explore cash flow quality index of Medical Developments International Ltd to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Bellavista Resources Ltd AU:BVR	-0.067x
Enegex Ltd AU:ENX	-0.061x
True North Copper Ltd AU:TNC	-0.033x
JR HOLDING SA BC ZY -10 F:8JA	0.000x
OCA Acquisition Corp NASDAQ:OCAX	-0.003x
Woory Industrial Co. Ltd KQ:215360	0.034x
Touax SCA PA:TOUP	0.021x
Aspocomp Group Oyj HE:ACG1V	0.034x

Annual Cash Flow Conversion Efficiency for Medical Developments International Ltd (2004–2025)

The table below shows the annual cash flow conversion efficiency of Medical Developments International Ltd from 2004 to 2025. View current stock price of Medical Developments International Ltd for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$55.10 Million ≈ $38.99 Million	AU$-43.00K ≈ $-30.43K	-0.001x	+99.67%
2024-06-30	AU$45.73 Million ≈ $32.36 Million	AU$-10.78 Million ≈ $-7.63 Million	-0.236x	-16.20%
2023-06-30	AU$81.31 Million ≈ $57.54 Million	AU$-16.50 Million ≈ $-11.67 Million	-0.203x	-8.40%
2022-06-30	AU$57.30 Million ≈ $40.54 Million	AU$-10.72 Million ≈ $-7.59 Million	-0.187x	-45.11%
2021-06-30	AU$68.30 Million ≈ $48.33 Million	AU$-8.81 Million ≈ $-6.23 Million	-0.129x	-3349.26%
2020-06-30	AU$43.34 Million ≈ $30.66 Million	AU$172.00K ≈ $121.70K	0.004x	-99.17%
2019-06-30	AU$44.59 Million ≈ $31.55 Million	AU$21.27 Million ≈ $15.05 Million	0.477x	+460.77%
2018-06-30	AU$21.04 Million ≈ $14.89 Million	AU$1.79 Million ≈ $1.27 Million	0.085x	-54.19%
2017-06-30	AU$21.60 Million ≈ $15.28 Million	AU$4.01 Million ≈ $2.84 Million	0.186x	-70.72%
2016-06-30	AU$19.02 Million ≈ $13.46 Million	AU$12.07 Million ≈ $8.54 Million	0.634x	+228.69%
2015-06-30	AU$17.41 Million ≈ $12.32 Million	AU$3.36 Million ≈ $2.38 Million	0.193x	+135.79%
2014-06-30	AU$15.82 Million ≈ $11.20 Million	AU$1.29 Million ≈ $916.30K	0.082x	+31.75%
2013-06-30	AU$15.73 Million ≈ $11.13 Million	AU$977.00K ≈ $691.29K	0.062x	-68.60%
2012-06-30	AU$16.17 Million ≈ $11.44 Million	AU$3.20 Million ≈ $2.26 Million	0.198x	-5.67%
2011-06-30	AU$14.46 Million ≈ $10.23 Million	AU$3.03 Million ≈ $2.14 Million	0.210x	+47.18%
2010-06-30	AU$12.71 Million ≈ $8.99 Million	AU$1.81 Million ≈ $1.28 Million	0.142x	+31.08%
2009-06-30	AU$11.81 Million ≈ $8.36 Million	AU$1.28 Million ≈ $908.51K	0.109x	+4.45%
2008-06-30	AU$11.80 Million ≈ $8.35 Million	AU$1.23 Million ≈ $868.89K	0.104x	-9.48%
2007-06-30	AU$11.02 Million ≈ $7.80 Million	AU$1.27 Million ≈ $896.48K	0.115x	-1.48%
2006-06-30	AU$9.87 Million ≈ $6.99 Million	AU$1.15 Million ≈ $815.11K	0.117x	+72.27%
2005-06-30	AU$8.40 Million ≈ $5.94 Million	AU$569.00K ≈ $402.60K	0.068x	+41.46%
2004-06-30	AU$8.37 Million ≈ $5.93 Million	AU$401.00K ≈ $283.73K	0.048x	--

About Medical Developments International Ltd

AU:MVP Australia Drug Manufacturers - Specialty & Generic

Market Cap

$38.26 Million

AU$54.08 Million AUD

Market Cap Rank

#22991 Global

#851 in Australia

Share Price

AU$0.48

Change (1 day)

-1.03%

52-Week Range

AU$0.37 - AU$0.76

All Time High

AU$11.06